NEW - Maintenance Agreement: Matersizer 3000

The Food and Drug Administration has issued a forecast for a new maintenance agreement covering the Matersizer 3000 Laser Diffraction Optical System, a specialized instrument used for particle size analysis in laboratory settings. This service contract is intended to ensure ongoing operational reliability and performance of the equipment through scheduled preventive maintenance, troubleshooting, repairs, and technical support. The agreement will likely include parts replacement, on-site or remote diagnostics, calibration services, and software updates to maintain compliance with regulatory standards for scientific equipment used in FDA-regulated environments. The contract is classified under NAICS code 811219, which pertains to other commercial and industrial machinery and equipment repair and maintenance. The posting date is listed as May 25, 2026, indicating this is a future forecast opportunity rather than a currently active solicitation. The point of contact for program inquiries is the NCTR Acquisition Liaison at nctracquisitions@fda.hhs.gov, while the Contracting Officer position remains unspecified as “To Be Determined.” There is no designated place of performance or set-aside designation, suggesting the service may be provided remotely or at any FDA facility where the instrument is deployed, with no specific socioeconomic preferences outlined. Stakeholders interested in bidding should monitor the OSDBU opportunity forecast link for updates as the procurement progresses toward a formal solicitation.